Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Ubidecarenone by BPGbio for Glioblastoma Multiforme (GBM): Likelihood of Approval
Ubidecarenone is under clinical development by BPGbio and currently in Phase II for Glioblastoma Multiforme (GBM). According to GlobalData, Phase...
Ubidecarenone by BPGbio for Sarcopenia: Likelihood of Approval
Ubidecarenone is under clinical development by BPGbio and currently in Phase I for Sarcopenia. According to GlobalData, Phase I drugs...
Ubidecarenone by BPGbio for Glioblastoma Multiforme (GBM): Likelihood of Approval
Ubidecarenone is under clinical development by BPGbio and currently in Phase II for Glioblastoma Multiforme (GBM). According to GlobalData, Phase...